Cargando…
Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease
Preeclampsia is a multifactorial cardiovascular disorder diagnosed after 20 weeks of gestation, and is the leading cause of death for both mothers and babies in pregnancy. The pathophysiology remains poorly understood due to the variability and unpredictability of disease manifestation when studied...
Autores principales: | Liu Chung Ming, Clara, Sesperez, Kimberly, Ben-Sefer, Eitan, Arpon, David, McGrath, Kristine, McClements, Lana, Gentile, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070848/ https://www.ncbi.nlm.nih.gov/pubmed/33919808 http://dx.doi.org/10.3390/cells10040899 |
Ejemplares similares
-
Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia
por: Richards, Claire, et al.
Publicado: (2021) -
Impact of reduced uterine perfusion pressure model of preeclampsia on metabolism of placenta, maternal and fetal hearts
por: McClements, Lana, et al.
Publicado: (2022) -
A placenta-on-a-chip model to determine the regulation of FKBPL and galectin-3 in preeclampsia
por: Ghorbanpour, Sahar Masoumeh, et al.
Publicado: (2023) -
Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia
por: Aneman, Ingrid, et al.
Publicado: (2020) -
Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation
por: Augustine, Robin, et al.
Publicado: (2022)